Position in SNWV
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$46,682
-$196,125 QoQ
Shares Held
2,700
-66.8% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNWV Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $3,733,772,666 across 105 Medical Devices names. SNWV ranks #74 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
15,909,341 | $1,633,412,039 | |
| 2 | SYK |
Stryker Corp
|
2,297,196 | $754,835,631 | |
| 3 | MDT |
Medtronic plc
|
7,514,778 | $651,155,511 | |
| 4 | BSX |
Boston Scientific Corp
|
2,971,322 | $186,450,453 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,081,271 | $86,588,179 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
1,150,789 | $81,913,158 | |
| 7 | DXCM |
Dexcom Inc
|
845,998 | $53,128,672 | |
| 8 | NVCR |
NovoCure Ltd
|
2,951,237 | $32,168,481 |
All Filings in SNWV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,682 | 2,700 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $242,807 | 8,137 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $161,500 | 4,309 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $119,084 | 3,624 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $212 | 6 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||